By Allan Maurer
BETHESDA, MD – United BioSource, a pharmaceutical services organization that helps established life sciences companies gather and analyze evidence to develop and commercialize their products, has raised $125 million from Boston-based Berkshire Partners.

In 2003, the year it was formed, the company raised $153 million in equity capital commitments through several investors: Whitney & Co. of Stamford, CT, Oak Investment Partners, of Westport, CT., and Grotech Capital Group, of Baltimore.

The company then made a considerable number of acquisitions of life sciences companies.

“UBC’s management team has an impressive record of successfully integrating acquisitions, creating value across business lines and servicing the world’s most progressive life sciences companies. We are excited to have a chance to partner with a clear leader and innovator in this space,” said Randy Peeler, managing director of Berkshire Partners.

UBC partners with life sciences companies to develop and commercialize medical products globally by providing impartial and timely real-world evidence that demonstrates safety, efficacy and value. UBC now has offices in more than 20 countries across the globe with over 1,300 employees.

Ethan Leder, CEO of United BioSource said, “With this additional capital investment, we are well positioned to continue our targeted growth strategy recognizing that over the last six years, a steady and accelerating momentum has been building among regulators, payors, physicians and patients for new requirements and standards that go beyond FDA approval and the traditional drug development process.

“These demands relate to the provision of a continuous stream of evidence of product safety, economic value and medical effectiveness in the pre- and post-approval environment,” Leder said.

Leder and Mark P. Clein founded the company. Previously, Leder and Clein founded a national specialty pharmaceutical distributor – US Bioservices Corporation, based in Washington, D.C. After acquiring several pharmaceutical distribution and services organizations, they sold the company to AmerisourceBergen Corporation (NYSE: ABC) for approximately $180 million in 2003.

Online: www.unitedbiosource.com

Southeast Venture Conference, February 29 – March 1, 2012 at the Ritz Carlton in Tysons Corner, VA – Where Smart Money Meets Smart People.
www.seventure.org

© 2009, TechJournal South. All rights reserved.